--- title: "Unitree's Series C values the Hangzhou robot maker near US$1.7B — and looks like an IPO rehearsal" date: 2026-09-28 category: Capital & Markets site: NeuroAI canonical: https://neuroai.site/a/na-capital-unitree-funding language: en --- # Unitree's Series C values the Hangzhou robot maker near US$1.7B — and looks like an IPO rehearsal > Unitree Robotics, the Hangzhou company behind the G1 and H1 humanoid robots, closed a Series C in 2025 that values it around RMB 12 billion (≈ US$1.7 billion / HK$13 billion). The round was led by China Mobile, Tencent, Alibaba, Ant and Geely — and the company quietly turned itself into a joint-stock firm, the classic first step toward an IPO. A humanoid robot that dances at the Spring Festival Gala just became a balance-sheet event. Unitree, the Hangzhou builder of cheap, capable legged machines, closed a funding round that values it like a serious hardware company — not a lab experiment. The tell was not the money. It was the paperwork. ## The round, in numbers Unitree completed its **Series C** in mid-2025, a round that had opened in late 2024. The verified figures: - **Valuation: about RMB 12 billion (≈ US$1.7 billion / HK$13 billion)** post-money; pre-money was already above RMB 10 billion. - **Round size: reported at around RMB 700 million (≈ US$98 million / HK$770 million)** — Unitree disclosed the valuation but not the exact amount, so this is a market estimate. - **Lead investors:** China Mobile's investment fund, Tencent, HongShan (锦秋), Alibaba, Ant Group and Geely Capital, with most earlier backers following on. - **Registered capital** jumped to **RMB 3.64 billion (≈ US$510 million / HK$4 billion)** in June 2025. Founder and CEO **Wang Xingxing (王兴兴)**, born in 1990, started the company alone in 2016. It now employs more than 1,000 people and, by his own statement at the 2025 Summer Davos forum, passed **RMB 1 billion (≈ US$140 million / HK$1.1 billion)** in annual revenue. ## Why the restructuring matters On 29 May 2025, the firm changed its name from "Hangzhou Unitree Technology Co." to "Hangzhou Unitree Technology Co., Ltd. (股份有限公司)" — a joint-stock company. Two weeks later its registered capital leapt 125-fold. In China, that corporate form is the doorway to a public listing. Multiple outlets reported that Unitree and its investors are pushing toward an IPO, with the A-share market the first choice and Hong Kong a fallback. Nobody has filed a prospectus, and the company has not confirmed a date. But the sequence — raise, restructure, hint — is the oldest script in Chinese tech. ## What Unitree actually sells Unlike most humanoid (人形机器人) startups, Unitree ships product today. - The **Go2** quadruped (四足机器人) starts under US$2,000 and is a default research platform worldwide. - The **G1** humanoid lists at about US$16,000 — a fraction of what rivals charge. - The **H1** is its "first universal humanoid robot," with over-the-air software updates. Unitree's edge is price. Its robots run up to 50% cheaper than comparable systems, which is why universities and R&D labs — not just show stages — buy them. An industry report cited by Chinese media puts Unitree's share of global quadruped (四足机器人) sales at roughly 70% in 2023, a dominance that explains why strategic investors, not just VCs, showed up. ## The risks behind the valuation Two cautions are worth stating plainly. First, **the round size is an estimate.** Unitree confirmed the valuation and the investor list but not the dollar amount; the RMB 700 million figure comes from Beijing Daily and industry estimates, not a company disclosure. Second, **humanoid (人形机器人) revenue is still young.** Wang himself has said large-scale deployments have not happened yet. The Gala performances are great theatre, but they are choreography, not proof of autonomous work in a warehouse. The valuation prices the future, not the floor. ## What readers can do now - **If you buy or build robotics:** Unitree's sub-US$20,000 humanoids are the volume play. Benchmark a G1 on a real task before assuming a pricier US or European humanoid is "more capable." - **If you follow listings:** watch for a formal IPO filing. The joint-stock conversion is the signal; a prospectus is the proof. Until then, "preparing for an IPO" is not "going public." - **If you invest:** separate valuation (RMB 12B / ≈ US$1.7B, verified) from round size (≈ RMB 700M / US$98M, estimated). The first is disclosed; the second is reported. ## Honest limitations Core facts — Series C closed mid-2025, ~RMB 12B (≈ US$1.7B) post-money valuation, pre-money above RMB 10B, China Mobile fund/Tencent/Alibaba/Ant/Geely/HongShan lead, joint-stock conversion on 29 May 2025, registered capital RMB 3.64B (≈ US$510M) on 18 June 2025, founder Wang Xingxing, 2016 founding, ~RMB 1B (≈ US$140M) annual revenue stated at 2025 Summer Davos, G1 at ~US$16,000, Go2 under US$2,000 — come from Beijing Daily (北京日报, 26 June 2025), The Robot Report (2025), Chinatimes/工商時報 (21 June 2025), Sina/长江商报 (23 June 2025), and Baidu Baike. The RMB 700M (≈ US$98M / HK$770M) round size is reported by Beijing Daily and The Robot Report ("some estimates put the round at US$97.6M") but was not officially disclosed by Unitree; treat as an estimate. The ~70% 2023 global quadruped share is cited by Chinese media attributing GGII (高工机器人产业研究所) and is an industry estimate. The IPO plan (A-share preferred, HKEX fallback) is reported but unconfirmed by Unitree; no filing or date exists. Currency: RMB 12B ÷ 7.1 ≈ US$1.7B, × 7.8 ≈ HK$13B; RMB 700M ≈ US$98M / HK$770M; RMB 1B ≈ US$140M / HK$1.1B; RMB 3.64B ≈ US$510M / HK$4B. Conversions approximate. Not investment advice. Current to 28 September 2026. --- Published by NeuroAI (https://neuroai.site/) — https://neuroai.site/a/na-capital-unitree-funding Free to quote with attribution and a link to the original.